• 3715 Citations
  • 32 h-Index
1979 …2017
If you made any changes in Pure these will be visible here soon.

Research Output 1979 2017

  • 3715 Citations
  • 32 h-Index
  • 85 Article
  • 3 Conference contribution
  • 2 Chapter
2017
3 Citations (Scopus)

Synthesis of dicarba-cyclooctapeptide Somatostatin analogs by conventional and MW-assisted RCM: A study about the impact of the configuration at Cα of selected amino acids

Pratesi, A., Stazzoni, S., Lumini, M., Sabatino, G., Carotenuto, A., Brancaccio, D., Novellino, E., Chinol, M., Rovero, P., Ginanneschi, M. & Papini, A. M., Dec 1 2017, In : Chemical Engineering and Processing: Process Intensification. 122, p. 365-372 8 p.

Research output: Contribution to journalArticle

Allylglycine
Somatostatin
Peptides
Amino acids
Amino Acids
2016
3 Citations (Scopus)

Lutetium-177 labeled peptides: The European institute of oncology experience

Carollo, A., Papi, S. & Chinol, M., Jan 1 2016, In : Current Radiopharmaceuticals. 9, 1, p. 19-32 14 p.

Research output: Contribution to journalArticle

Lutetium
Somatostatin Receptors
Peptides
Radioisotopes
Neoplasms
2015
3 Citations (Scopus)

Design and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomers

Pratesi, A., Ginanneschi, M., Melani, F., Chinol, M., Carollo, A., Paganelli, G., Lumini, M., Bartoli, M., Frediani, M., Rosi, L., Petrucci, G., Messori, L. & Papini, A. M., Apr 7 2015, In : Organic and Biomolecular Chemistry. 13, 13, p. 3988-4001 14 p.

Research output: Contribution to journalArticle

Solid-Phase Synthesis Techniques
biotin
Avidin
Biotin
oligomers
13 Citations (Scopus)

New radiopharmaceutical agents for the treatment of castration-resistant prostate cancer

Maffioli, L., Florimonte, L., Costa, D. C., Castanheira, J. C., Grana, C., Luster, M., Bodei, L. & Chinol, M., Dec 1 2015, In : Quarterly Journal of Nuclear Medicine and Molecular Imaging. 59, 4, p. 420-438 19 p.

Research output: Contribution to journalArticle

Radiopharmaceuticals
Castration
Prostatic Neoplasms
Bone and Bones
Bombesin Receptors
2013
1 Citation (Scopus)

Production and quality control of [90Y]DOTATOC for treatment of metastatic neuroendocrine tumors: Results of 85 syntheses

Biasiotto, G., Bertagna, F., Zanella, I., Biasiotto, U., Savelli, G., Caimi, L., Bettinsoli, G., Giubbini, R. & Chinol, M., Mar 2013, In : Nuclear Medicine Communications. 34, 3, p. 265-270 6 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Quality Control
Radioactivity
Therapeutics
DOTA-Tyr(3)-90Y-octreotide
2012
5 Citations (Scopus)

Eleven-year experience with the avidin-biotin pretargeting system in glioblastoma: Toxicity, efficacy and survival

Grana, C. M., Chinol, M., de Cicco, C., Bartolomei, M., Cremonesi, M., Bodei, L., Rocca, P. A., Pacifici, M., Tiberini, S., Baio, S. M., Broggi, G., Severi, S. & Paganelli, G., 2012, In : Open Nuclear Medicine Journal. 4, p. 14-20 7 p.

Research output: Contribution to journalArticle

Avidin
Glioblastoma
Biotin
Survival
Radioimmunotherapy
12 Citations (Scopus)

Yttrium-90 - current status, expected availability and applications of a high beta energy emitter

Leyva Montaña, R., Hernández González, I., Alberti Ramirez, A., Garaboldi, L. & Chinol, M., Jul 2012, In : Current Radiopharmaceuticals. 5, 3, p. 253-263 11 p.

Research output: Contribution to journalArticle

Yttrium
Radioisotopes
Radionuclide Generators
Antibodies
Strontium
33 Citations (Scopus)

Yttrium-labelled peptides for therapy of NET

Bodei, L., Cremonesi, M., Grana, C. M., Chinol, M., Baio, S. M., Severi, S. & Paganelli, G., Feb 2012, In : European Journal of Nuclear Medicine and Molecular Imaging. 39, SUPPL.1

Research output: Contribution to journalArticle

Yttrium
Radioisotopes
Peptides
Peptide Receptors
Neoplasms
2011
194 Citations (Scopus)

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: The IEO phase I-II study

Bodei, L., Cremonesi, M., Grana, C. M., Fazio, N., Iodice, S., Baio, S. M., Bartolomei, M., Lombardo, D., Ferrari, M. E., Sansovini, M., Chinol, M. & Paganelli, G., Dec 2011, In : European Journal of Nuclear Medicine and Molecular Imaging. 38, 12, p. 2125-2135 11 p.

Research output: Contribution to journalArticle

Peptide Receptors
Radioisotopes
Kidney
Bone Marrow
Activity Cycles
10 Citations (Scopus)

Preclinical evaluation of 177Lu-Nimotuzumab: A potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors

Vera, D. R. B., Eigner, S., Beran, M., Henke, K. E., Laznickova, A., Laznicek, M., Melichar, F. & Chinol, M., Jun 1 2011, In : Cancer Biotherapy and Radiopharmaceuticals. 26, 3, p. 287-297 11 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Immunoconjugates
Epidermal Growth Factor Receptor
Neoplasms
Pentetic Acid
2010
16 Citations (Scopus)

AvidinOX™ for highly efficient tissue-pretargeted radionuclide therapy

De Santis, R., Leoni, B., Rosi, A., Albertoni, C., Forni, G., Cojoca, R., Iezzi, M., Musiani, P., Paganelli, G., Chinol, M. & Carminati, P., Apr 1 2010, In : Cancer Biotherapy and Radiopharmaceuticals. 25, 2, p. 143-148 6 p.

Research output: Contribution to journalArticle

Avidin
Radioisotopes
Biotin
Therapeutics
Schiff Bases
6 Citations (Scopus)

Biotin derivatives carrying two chelating DOTA units. Synthesis, in vitro evaluation of biotinidases resistance, avidin binding, and radiolabeling tests

Pratesi, A., Bucelli, F., Mori, I., Chinol, M., Verdoliva, A., Paganelli, G., Rivieccio, V., Gariboldi, L. & Ginanneschi, M., 2010, In : Journal of Medicinal Chemistry. 53, 1, p. 432-440 9 p.

Research output: Contribution to journalArticle

Biotinidase
Avidin
Biotin
Lysine
4-Aminobenzoic Acid
9 Citations (Scopus)

Radiolabeling optimization and reduced staff radiation exposure for high-dose 90Y-ibritumomab tiuxetan (HD-Zevalin)

Papi, S., Martano, L., Garaboldi, L., Rossi, A., Cremonesi, M., Grana, C. M., Paolucci, D., Sansovini, M., Paganelli, G. & Chinol, M., Jan 2010, In : Nuclear Medicine and Biology. 37, 1, p. 85-93 9 p.

Research output: Contribution to journalArticle

Fingers
Safety
Radiation Protection
Nuclear Medicine
Radiation Exposure
3 Citations (Scopus)
Validation Studies
Clinical Trials
Radiopharmaceuticals
Infertility
Hospital Laboratories
2009
13 Citations (Scopus)

Rapid determination of 90Sr impurities in freshly "generator eluted" 90Y for radiopharmaceutical preparation

Bonardi, M. L., Martano, L., Groppi, F. & Chinol, M., Oct 2009, In : Applied Radiation and Isotopes. 67, 10, p. 1874-1877 4 p.

Research output: Contribution to journalArticle

generators
impurities
preparation
resins
radioactive isotopes
2008

177Lu specific activity influence over DOTATATE radiolabeling: experimental data

Papi, S., Garaboldi, L., Martano, L., Paganelli, G. & Chinol, M., 2008, Transactions of the American Nuclear Society. Vol. 98. p. 845-846 2 p.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

7 Citations (Scopus)

Accurate determination of half-life and radionuclidic purity of reactor produced 177gLu (177mLu) for metabolic radiotherapy

Canella, L., Bonardi, M. L., Groppi, F., Persico, E., Zona, C., Menapace, E., Alfassi, Z. B., Chinol, M., Papi, S. & Tosi, G., Jun 2008, In : Journal of Radioanalytical and Nuclear Chemistry. 276, 3, p. 813-818 6 p.

Research output: Contribution to journalArticle

Nuclear medicine
Radiotherapy
Nuclear reactors
Radioisotopes
Ground state
1 Citation (Scopus)

Radiochemical separations: Useful methods for the preparation of no-carrier-added solutions of different radionuclides for metabolic radiotherapy

Zona, C., Groppi, F., Persico, E., Canella, L., Bonardi, M. L., Chinol, M., Abbas, K., Holzwarth, U. & Gibson, N., 2008, Astroparticle, Particle and Space Physics, Detectors and Medical Physics Applications - Proceedings of the 10th Conference. p. 711-715 5 p.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

radiochemical separation
radioactive isotopes
radiation therapy
preparation
emitters
2007
39 Citations (Scopus)

Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT®)

Urbano, N., Papi, S., Ginanneschi, M., De Santis, R., Pace, S., Lindstedt, R., Ferrari, L., Choi, S., Paganelli, G. & Chinol, M., Jan 2007, In : European Journal of Nuclear Medicine and Molecular Imaging. 34, 1, p. 68-77 10 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Avidin
Antibodies
Ascorbic Acid
Neoplasms
30 Citations (Scopus)
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Blood Cells
Stem Cells
Stem Cell Transplantation
20 Citations (Scopus)

Intraoperative avidination for radionuclide therapy: A prospective new development to accelerate radiotherapy in breast cancer

Paganelli, G., Ferrari, M., Ravasi, L., Cremonesi, M., De Cicco, C., Galimberti, V., Sivolapenko, G., Luini, A., De Santis, R., Travaini, L. L., Fiorenza, M., Chinol, M., Papi, S., Zanna, C., Carminati, P. & Veronesi, U., Sep 15 2007, In : Clinical Cancer Research. 13, 18

Research output: Contribution to journalArticle

Radioisotopes
Breast
Radiotherapy
Avidin
Breast Neoplasms

Radioimmimotherapy in high grade gliomas

Bartolomei, M., Grana, C., Ferrari, M., Boiardi, A., Chinol, M. & Paganelli, G., Dec 2007, In : Rivista Medica. 13, 4, p. 97-104 8 p.

Research output: Contribution to journalArticle

Glioma
Radioimmunotherapy
Radiotherapy
Monoclonal Antibodies
Drug Therapy
2006
1 Citation (Scopus)

Accurate determination of radionuclide purity and half-life of reactor produced LU-177G for metabolic radioimmunotherapy

Groppi, F., Canella, L., Bonardi, M. L., Zona, C., Morzenti, S., Menapace, E., Alfassi, Z. B., Chinol, M., Papi, S. & Tosi, G., 2006, Astroparticle, Particle and Space Physics, Detectors and Medical Physics Applications - Proceedings of the 9th Conference. p. 710-714 5 p.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

half life
radioactive isotopes
purity
reactors
decay
24 Citations (Scopus)

Dosimetric model for locoregional treatments of brain tumors with 90Y-conjugates: Clinical application with 90Y-DOTATOC

Ferrari, M., Cremonesi, M., Bartolomei, M., Bodei, L., Chinol, M., Fiorenza, M., Tosi, G. & Paganelli, G., Jan 1 2006, In : Journal of Nuclear Medicine. 47, 1, p. 105-112 8 p.

Research output: Contribution to journalArticle

Brain Neoplasms
Brain
Therapeutics
Octreotide
DOTA-Tyr(3)-90Y-octreotide
17 Citations (Scopus)

Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody

De Santis, R., Albertoni, C., Petronzelli, F., Campo, S., D'Alessio, V., Rosi, A., Anastasi, A. M., Lindstedt, R., Caroni, N., Arseni, B., Chiodi, P., Verdoliva, A., Cassani, G., Chinol, M., Paganelli, G. & Carminati, P., Apr 1 2006, In : Clinical Cancer Research. 12, 7 I, p. 2191-2196 6 p.

Research output: Contribution to journalArticle

Tenascin
Monoclonal Antibodies
Neoplasms
Radioimmunotherapy
Glioblastoma
32 Citations (Scopus)

Radiation protection in radionuclide therapies with 90Y- conjugates: Risks and safety

Cremonesi, M., Ferrari, M., Paganelli, G., Rossi, A., Chinol, M., Bartolomei, M., Prisco, G. & Tosi, G., Nov 2006, In : European Journal of Nuclear Medicine and Molecular Imaging. 33, 11, p. 1321-1327 7 p.

Research output: Contribution to journalArticle

Radiation Protection
Radioisotopes
Safety
Polymethyl Methacrylate
Peptides
37 Citations (Scopus)

Radioimmunotherapy of brain tumor

Paganelli, G., Bartolomei, M., Grana, C., Ferrari, M., Rocca, P. & Chinol, M., Jul 2006, In : Neurological Research. 28, 5, p. 518-522 5 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Brain Neoplasms
Radioisotopes
Monoclonal Antibodies
Neoplasms
2005
7 Citations (Scopus)

Evaluation of fresh and old eluate of 99Mo/99mTc generators used for labeling of different pharmaceutical kits

Urbano, N., Modoni, S., Guerra, M. & Chinol, M., Jun 2005, In : Journal of Radioanalytical and Nuclear Chemistry. 265, 1, p. 7-10 4 p.

Research output: Contribution to journalArticle

Radiopharmaceuticals
Drug products
Labeling
Pharmaceutical Preparations
Radioactivity
329 Citations (Scopus)

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs

Kwekkeboom, D. J., Mueller-Brand, J., Paganelli, G., Anthony, L. B., Pauwels, S., Kvols, L. K., O'Dorisio, T. M., Valkema, R., Bodei, L., Chinol, M., Maecke, H. R. & Krenning, E. P., Jan 1 2005, In : Journal of Nuclear Medicine. 46, 1 SUPPL.

Research output: Contribution to journalArticle

Peptide Receptors
Somatostatin
Radioisotopes
Octreotide
Therapeutics
21 Citations (Scopus)

Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugates

Salmaso, S., Semenzato, A., Bersania, S., Chinol, M., Paganelli, G. & Caliceti, P., Oct 30 2005, In : BBA - General Subjects. 1726, 1, p. 57-66 10 p.

Research output: Contribution to journalArticle

Ethylene Glycol
Avidin
Polyethylene glycols
Catalytic Domain
Biotin
7 Citations (Scopus)

Simple and safe production of yttrium-90 from a new type of 90Sr/90Y generator

Du, J., Chinol, M., Savonen, A. & Hiltunen, J., 2005, In : Radiochimica Acta. 93, 2, p. 111-113 3 p.

Research output: Contribution to journalArticle

Cation Exchange Resins
Yttrium
Chelating Agents
Chelation
yttrium
2004
31 Citations (Scopus)

Radioimmunotherapy in advanced ovarian cancer: Is there a role for pre-targeting with 90Y-biotin?

Grana, C., Bartolomei, M., Handkiewicz, D., Rocca, P., Bodei, L., Colombo, N., Chinol, M., Mangioni, C., Malavasi, F. & Paganelli, G., Jun 2004, In : Gynecologic Oncology. 93, 3, p. 691-698 8 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Biotin
Ovarian Neoplasms
Avidin
Therapeutics
169 Citations (Scopus)

Receptor radionuclide therapy with 90Y-[DOTA] 0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

Bodei, L., Cremonesi, M., Grana, C., Rocca, P., Bartolomei, M., Chinol, M. & Paganelli, G., Jul 2004, In : European Journal of Nuclear Medicine and Molecular Imaging. 31, 7, p. 1038-1046 9 p.

Research output: Contribution to journalArticle

Octreotide
Neuroendocrine Tumors
Radioisotopes
Somatostatin Receptors
Somatostatin
66 Citations (Scopus)

Receptor Radionuclide Therapy with 90Y-DOTATOC in Patients with Medullary Thyroid Carcinomas

Bodei, L., Handkiewicz-Junak, D., Grana, C., Mazzetta, C., Rocca, P., Bartolomei, M., Sierra, M. L., Cremonesi, M., Chinol, M., Mäcke, H. R. & Paganelli, G., 2004, In : Cancer Biotherapy and Radiopharmaceuticals. 19, 1, p. 65-71 7 p.

Research output: Contribution to journalArticle

Octreotide
Radioisotopes
Therapeutics
Calcitonin
Medullary Thyroid cancer
2003
41 Citations (Scopus)

A new biotin derivative-DOTA conjugate as a candidate for pretargeted diagnosis and therapy of tumors

Sabatino, G., Chinol, M., Paganelli, G., Papi, S., Chelli, M., Leone, G., Papini, A. M., De Luca, A. & Ginanneschi, M., Jul 3 2003, In : Journal of Medicinal Chemistry. 46, 14, p. 3170-3173 4 p.

Research output: Contribution to journalArticle

Biotinidase
Avidin
Carbon Monoxide
Chelating Agents
Biotin
21 Citations (Scopus)

Improved radiotracing of oxytocin receptor-expressing tumours using the new [111 In]-DOTA-Lys8-deamino-vasotocin analogue

Chini, B., Chinol, M., Cassoni, P., Papi, S., Reversi, A., Areces, L., Marrocco, T., Paganelli, G., Manning, M. & Bussolati, G., Sep 1 2003, In : British Journal of Cancer. 89, 5, p. 930-936 7 p.

Research output: Contribution to journalArticle

Oxytocin Receptors
Vasotocin
Oxytocin
Neoplasms
Vasopressin Receptors
13 Citations (Scopus)

Localization of Avidin in Superficial Bladder Cancer: A Potentially New Approach for Radionuclide Therapy

Chinol, M., De Cobelli, O., Trifirò, G., Scardino, E., Bartolomei, M., Verweij, F., Papi, S., Matei, D. V. & Paganelli, G., Nov 2003, In : European Urology. 44, 5, p. 556-559 4 p.

Research output: Contribution to journalArticle

Avidin
Urinary Bladder Neoplasms
Radioisotopes
Biotin
Intravesical Administration
31 Citations (Scopus)

Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioimmunoTherapy (PAGRITR)

De Santis, R., Anastasi, A. M., D'Alessio, V., Pelliccia, A., Albertoni, C., Rosi, A., Leoni, B., Lindstedt, R., Petronzelli, F., Dani, M., Verdoliva, A., Ippolito, A., Campanile, N., Manfredi, V., Esposito, A., Cassani, G., Chinol, M., Paganelli, G. & Carminati, P., Apr 7 2003, In : British Journal of Cancer. 88, 7, p. 996-1003 8 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Hybridomas
Monoclonal Antibodies
Antibodies
Epitopes
251 Citations (Scopus)

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: A phase I study

Bodei, L., Cremonesi, M., Zoboli, S., Grana, C., Bartolomei, M., Rocca, P., Caracciolo, M., Mäcke, H. R., Chinol, M. & Paganelli, G., Feb 1 2003, In : European Journal of Nuclear Medicine and Molecular Imaging. 30, 2, p. 207-216 10 p.

Research output: Contribution to journalArticle

Radioisotopes
Amino Acids
Kidney
Renal Agents
Activity Cycles
2002
90 Citations (Scopus)

90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies

Paganelli, G., Bodei, L., Handkiewicz Junak, D., Rocca, P., Papi, S., Lopera Sierra, M., Gatti, M., Chinol, M., Bartolomei, M., Fiorenza, M. & Grana, C., 2002, In : Biopolymers. 66, 6, p. 393-398 6 p.

Research output: Contribution to journalArticle

Octreotide
Tumors
Neuroendocrine Tumors
Somatostatin
Neoplasms
10 Citations (Scopus)

Facts and myths about radiopeptide therapy: Scylla, Charybdis and Sibyl [2]

Bodei, L., Chinol, M., Cremonesi, M. & Paganelli, G., 2002, In : European Journal Of Nuclear Medicine. 29, 8, p. 1099-1100 2 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Optimization of antibody labeling with rhenium-188 using a prelabeled MAG3 chelate

Crudo, J. L., Edreira, M. M., Obenaus, E. R., Chinol, M., Paganelli, G. & De Castiglia, S. G., Nov 6 2002, In : International Journal of Pharmaceutics. 248, 1-2, p. 173-182 10 p.

Research output: Contribution to journalArticle

Rhenium
Immunoglobulin G
Inflammation
Antibodies
Protein Stability
46 Citations (Scopus)

Poly(ethylene glycol)-avidin bioconjugates: Suitable candidates for tumor pretargeting

Caliceti, P., Chinol, M., Roldo, M., Veronese, F. M., Semenzato, A., Salmaso, S. & Paganelli, G., Sep 18 2002, In : Journal of Controlled Release. 83, 1, p. 97-108 12 p.

Research output: Contribution to journalArticle

Ethylene Glycol
Avidin
Neoplasms
Biotin
Proteins
127 Citations (Scopus)

Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study

Grana, C., Chinol, M., Robertson, C., Mazzetta, C., Bartolomei, M., De Cicco, C., Fiorenza, M., Gatti, M., Caliceti, P. & Paganelli, G., Jan 21 2002, In : British Journal of Cancer. 86, 2, p. 207-212 6 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Yttrium
Biotin
Glioma
Glioblastoma
114 Citations (Scopus)
Octreotide
Radiotherapy
Somatostatin
Neoplasms
Somatostatin Receptors
2001
16 Citations (Scopus)

111In-labeled 1,4,7,10-tetraazacyclododecane- N,N′,N″,N‴-tetraacetic acid-Lys8-vasotocin: A new powerful radioligand for oxytocin receptor-expressing tumors

Bussolati, G., Chinol, M., Chini, B., Nacca, A., Cassoni, P. & Paganelli, G., Jun 1 2001, In : Cancer Research. 61, 11, p. 4393-4397 5 p.

Research output: Contribution to journalArticle

Oxytocin Receptors
Vasotocin
Acids
Glioblastoma
Breast Neoplasms
108 Citations (Scopus)

Pre-targeted locoregional radioimmunotheraphy with 90Y-biotin in glioma patients: Phase I study and preliminary therapeutic results

Paganelli, G., Bartolomei, M., Ferrari, M., Cremonesi, M., Broggi, G., Maira, G., Sturiale, C., Grana, C., Prisco, G., Gatti, M., Caliceti, P. & Chinol, M., 2001, In : Cancer Biotherapy and Radiopharmaceuticals. 16, 3, p. 227-235 9 p.

Research output: Contribution to journalArticle

Biotin
Glioma
Astrocytoma
Glioblastoma
Radioimmunotherapy
189 Citations (Scopus)

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

Paganelli, G., Zoboli, S., Cremonesi, M., Bodei, L., Ferrari, M., Grana, C., Bartolomei, M., Orsi, F., De Cicco, C., Mäcke, H. R., Chinol, M. & De Braud, F., 2001, In : European Journal Of Nuclear Medicine. 28, 4, p. 426-434 9 p.

Research output: Contribution to journalArticle

Octreotide
Radiotherapy
Somatostatin Receptors
Maximum Tolerated Dose
Kidney
12 Citations (Scopus)

The humoral immune response to macrocyclic chelating agent DOTA depends on the carrier molecule

Perico, M. E., Chinol, M., Nacca, A., Luison, E., Paganelli, G. & Canevari, S., 2001, In : Journal of Nuclear Medicine. 42, 11, p. 1697-1703 7 p.

Research output: Contribution to journalArticle

Octreotide
Chelating Agents
Humoral Immunity
Somatostatin Receptors
Peptides